cp wire

CP Wire Articles

Inflazome Completes $45 Million Series B Round

Inflazome, a pioneering inflammasome company developing small molecule drugs that block harmful inflammation, today announces the successful completion of a Series B financing round of €40 million... read more

Mon, 11/19/18 - 09:19 am
Rocket Pharmaceuticals' IND for Gene Therapy for Immune Disorder Cleared by FDA
  • Without a successful bone marrow transplant, mortality in patients with severe LAD-I is 60-75% prior to the age of 2
  • The disease occurs in approximately 1 in 1 million births... read more
Mon, 11/19/18 - 08:59 am
Immunicum Announces Collaboration with Merck KGaA and Pfizer to Evaluate Cell Therapy Treatment in Combination with Avelumab

Immunicum will initiate a study of ilixadencel in the fourth quarter of 2018. Following completion of the Ib portion of the study, a Phase II study will be conducted using the checkpoint inhibitor... read more

Fri, 11/16/18 - 08:28 am
UCB Debuts AI Powered Virtual Assistant Parkinson's Disease App

UCB, a global biopharmaceutical company working in Parkinson’s disease (PD) and other chronic illnesses, and Verint Systems Inc. (Nasdaq: VRNT), announced on 11/15/18 the release of UCB’s PD Coach... read more

Thu, 11/15/18 - 09:18 am
Bayer’s Regorafenib is the First Drug in Innovative Global Glioblastoma Platform Trial
  • GBM AGILE is backed by more than 150 collaborators around the world
  • GBM treatment options and patient outcomes have remained largely unchanged over several decades and there is no... read more
Wed, 11/14/18 - 09:36 am

Pages